Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU462366B2 - Process for the purification of native highly purified plasminogen - Google Patents
[go: Go Back, main page]

AU462366B2 - Process for the purification of native highly purified plasminogen - Google Patents

Process for the purification of native highly purified plasminogen

Info

Publication number
AU462366B2
AU462366B2 AU28829/71A AU2882971A AU462366B2 AU 462366 B2 AU462366 B2 AU 462366B2 AU 28829/71 A AU28829/71 A AU 28829/71A AU 2882971 A AU2882971 A AU 2882971A AU 462366 B2 AU462366 B2 AU 462366B2
Authority
AU
Australia
Prior art keywords
purification
highly purified
purified plasminogen
native
native highly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU28829/71A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Publication of AU462366B2 publication Critical patent/AU462366B2/en
Expired legal-status Critical Current

Links

AU28829/71A Process for the purification of native highly purified plasminogen Expired AU462366B2 (en)

Publications (1)

Publication Number Publication Date
AU462366B2 true AU462366B2 (en)

Family

ID=

Similar Documents

Publication Publication Date Title
US5679790A (en) 2- 1-(1,3-thiazolin-2-yl)azetidin-3-yl!thio-carbapenem derivatives
AU616824B2 (en) Condensed benzene derivatives for use in treatment of cerebral disorders
US5202029A (en) Process for purification of hmg-coa reductase inhibitors
US4925935A (en) Methods for the manufacture of (1R,5S,6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl]thio-6-[R-1-hydroxyethyl]-1-methyl-carbapenem-3-carboxylate
AU462366B2 (en) Process for the purification of native highly purified plasminogen
CA2818465C (en) Process for the preparation of nebivolol
FI20002866A0 (en) Process for purification of moltose
IL154376A0 (en) Stereoselective reduction of substituted oxo-butanes
KR960004367A (en) Preparation method of α1-antichymotrypsin
HU212448B (en) Process for producing propionic acid derivatives
Miura et al. Lactacystin increases LDL receptor level on HepG2 cells
MX2025010908A (en) Improved method of purifying botulinum toxin using multimodal chromatography
US3758488A (en) Process for preparing thiazole derivatives
NZ547641A (en) A new process for preparation of imipenem
JP3078599B2 (en) Method for producing L-3,4-dihydroxyphenylserine derivative
MX2025002759A (en) Novel process for purifying heparan-n-sulfatase
CA3304225A1 (en) Process for the purification of perfluoroalkyl acids
AU277673B2 (en) Continuous process for the monohalogenation of acetone
AU133835B2 (en) Process for the manufacture of condention products
AU458971B2 (en) Process for the arylation of olefines
SU1655986A1 (en) Method for isolation of endonuclease restriction apa 1
JPS62212388A (en) (1r)-1-substituted carbapenem-3-carboxylic acid derivative
JPH04144695A (en) Reholding method of secretory protein
TW200519123A (en) A novel process to recover and purify acarbose from fermentation broth
US3702328A (en) Process for preparing thiazole derivatives